Rare diseases
Investigational molecules
Locations
Back to Spain761 clinical trials in Pamplona, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Long‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
SpainStudy of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers
SpainProphylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)
SpainFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
SpainA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
SpainPhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
SpainA Phase II Study of Cadonilimab Plus Lenvatinib Versus Lenvatinib in Advanced Hepatocellular Carcinoma After Atezolizumab/Bevacizumab Progression
SpainEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
SpainStudy of Pivekimab Sunirine Combined with Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
SpainStudy of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients
SpainDurvalumab plus drug combination as total neoadjuvant therapy for patients with resectable gastroesophageal adenocarcinoma
SpainPhase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for various cancers, including metastatic colorectal cancer, bladder cancer, and prostate cancer. Studies focus on combination therapies and novel treatment approaches.
Multiple trials evaluating immunotherapies and targeted treatments for improving patient outcomes.
Research focused on treating autoimmune conditions and inflammatory disorders, including studies on cutaneous lupus erythematosus and atopic dermatitis.
Evaluating new therapeutic approaches for chronic inflammatory conditions.
Clinical investigations targeting respiratory conditions, including studies on COPD and respiratory viral infections. Research focuses on improving treatment outcomes.
Development of innovative therapies for respiratory diseases and infections.
Studies addressing obesity, diabetes, and related metabolic conditions. Research focuses on weight management and blood sugar control.
Investigating new approaches for metabolic disorder management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
